Data / Drug companies / Carboprost tromethamine
Carboprost tromethamine: 22 companies and 25 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Carboprost tromethamine is listed in the FDA National Drug Code Directory by 22 companies, with 25 products in commercial distribution. 24 of the products (96.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; solution; injection, and the newest product started marketing on September 15, 2026.
The request: Get every company that lists carboprost tromethamine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 22
- Products
- 25
- Generic (ANDA) products
- 24 (96.0%)
- Application numbers
- 14
- Routes
- Intramuscular
- Brand names
- Hemabate
- openFDA record search
- api.fda.gov
Companies that list carboprost tromethamine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Dr. Reddy's Laboratories Inc. | 4 | injection, solution | Generic drugs (ANDA) | January 12, 2024 |
| Alembic Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | June 15, 2023 |
| Alembic Pharmaceuticals Limited | 1 | injection, solution | Generic drugs (ANDA) | June 15, 2023 |
| Amneal Pharmaceuticals LLC | 1 | injection, solution | Generic drugs (ANDA) | January 30, 2022 |
| Ani Pharmaceuticals, Inc. | 1 | injection | Generic drugs (ANDA) | December 20, 2024 |
| Armas Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | September 15, 2026 |
| Be Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 11, 2023 |
| Caplin Steriles Limited | 1 | injection, solution | Generic drugs (ANDA) | January 20, 2025 |
| Eugia US LLC | 1 | injection, solution | Generic drugs (ANDA) | May 25, 2023 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | June 12, 2023 |
| Gland Pharma Limited | 1 | injection, solution | Generic drugs (ANDA) | August 7, 2023 |
| Hikma Pharmaceuticals USA Inc. | 1 | solution | Generic drugs (ANDA) | March 3, 2026 |
| Hospira, Inc. | 1 | injection, solution | Generic drugs (ANDA) | April 15, 2024 |
| Long Grove Pharmaceuticals, LLC | 1 | injection | Generic drugs (ANDA) | October 15, 2022 |
| Micro Labs Limited | 1 | injection, solution | Generic drugs (ANDA) | August 1, 2024 |
| Omnivium Pharmaceuticals LLC. | 1 | injection, solution | Generic drugs (ANDA) | May 15, 2025 |
| Onesource Specialty Pharma Limited | 1 | injection, solution | Generic drugs (ANDA) | November 1, 2023 |
| Pharmacia & Upjohn Company LLC | 1 | injection, solution | New drug applications (NDA) | January 9, 1979 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | December 1, 2025 |
| Sola Pharmaceuticals, LLC | 1 | injection, solution | Generic drugs (ANDA) | September 25, 2023 |
| Somerset Therapeutics, LLC | 1 | injection, solution | Generic drugs (ANDA) | June 5, 2026 |
| Xellia Pharmaceuticals USA LLC | 1 | solution | Generic drugs (ANDA) | November 1, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 21 | 84% |
| Solution | 2 | 8% |
| Injection | 2 | 8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 24 | 96% |
| New drug applications (NDA) | 1 | 4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Prostaglandin Analog | 25 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.